Trick and treat

Ambushing recurrent tumors before they get out of the door

Nicolas Boisgerault, Richard Geoffrey Vile

Research output: Contribution to journalArticle

Abstract

Monitoring and treating dormant tumors represents a major clinical challenge. We have recently found that early recurring tumors elicit an innate immune response that can be detected systemically. We also demonstrated that it may be possible to target minimal residual disease before or after immune evasion with carefully timed, rational therapeutic approaches.

Original languageEnglish (US)
Article numbere27811
JournalOncoImmunology
Volume3
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Immune Evasion
Residual Neoplasm
Innate Immunity
Neoplasms
Therapeutics

Keywords

  • Innate immune response
  • Minimum residual disease
  • Tumor dormancy
  • Tumor recurrence
  • VEGF

ASJC Scopus subject areas

  • Immunology and Allergy
  • Oncology
  • Immunology

Cite this

Trick and treat : Ambushing recurrent tumors before they get out of the door. / Boisgerault, Nicolas; Vile, Richard Geoffrey.

In: OncoImmunology, Vol. 3, No. 1, e27811, 2014.

Research output: Contribution to journalArticle

@article{8126fc70b8784b9ca30ac83f68cca706,
title = "Trick and treat: Ambushing recurrent tumors before they get out of the door",
abstract = "Monitoring and treating dormant tumors represents a major clinical challenge. We have recently found that early recurring tumors elicit an innate immune response that can be detected systemically. We also demonstrated that it may be possible to target minimal residual disease before or after immune evasion with carefully timed, rational therapeutic approaches.",
keywords = "Innate immune response, Minimum residual disease, Tumor dormancy, Tumor recurrence, VEGF",
author = "Nicolas Boisgerault and Vile, {Richard Geoffrey}",
year = "2014",
doi = "10.4161/onci.27716",
language = "English (US)",
volume = "3",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Landes Bioscience",
number = "1",

}

TY - JOUR

T1 - Trick and treat

T2 - Ambushing recurrent tumors before they get out of the door

AU - Boisgerault, Nicolas

AU - Vile, Richard Geoffrey

PY - 2014

Y1 - 2014

N2 - Monitoring and treating dormant tumors represents a major clinical challenge. We have recently found that early recurring tumors elicit an innate immune response that can be detected systemically. We also demonstrated that it may be possible to target minimal residual disease before or after immune evasion with carefully timed, rational therapeutic approaches.

AB - Monitoring and treating dormant tumors represents a major clinical challenge. We have recently found that early recurring tumors elicit an innate immune response that can be detected systemically. We also demonstrated that it may be possible to target minimal residual disease before or after immune evasion with carefully timed, rational therapeutic approaches.

KW - Innate immune response

KW - Minimum residual disease

KW - Tumor dormancy

KW - Tumor recurrence

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=84899089801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899089801&partnerID=8YFLogxK

U2 - 10.4161/onci.27716

DO - 10.4161/onci.27716

M3 - Article

VL - 3

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 1

M1 - e27811

ER -